Selected research
Industry Research
mRNA Drug Industry Research Report 2026
Market perspective
The global mRNA Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for mRNA Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for mRNA Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for mRNA Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of mRNA Drug include Janssen, Sri Lankan Microorganisms, Pfizer, Fosun Pharma, AstraZeneca, Zydus Cadila, Moderna, CureVAC and BioNtech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global mRNA Drug market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
mRNA Drug Market by Company
Janssen
Sri Lankan Microorganisms
Pfizer
Fosun Pharma
AstraZeneca
Zydus Cadila
Moderna
CureVAC
BioNtech
mRNA Drug Segment by Type
Therapeutic Vaccine
Therapeutic Drugs
Preventive Vaccines
mRNA Drug Segment by Application
Hospital
Clinic
mRNA Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global mRNA Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of mRNA Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of mRNA Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of mRNA Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of mRNA Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of mRNA Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Therapeutic Vaccine
- Therapeutic Drugs
- Preventive Vaccines
Applications
- Hospital
- Clinic
Companies covered
- Janssen
- Sri Lankan Microorganisms
- Pfizer
- Fosun Pharma
- AstraZeneca
- Zydus Cadila
- Moderna
- CureVAC
- BioNtech
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global mRNA Drug Market Size (2021-2032)
- 2.2.2 Global mRNA Drug Sales (2021-2032)
- 2.2.3 Global mRNA Drug Market Average Price (2021-2032)
- 2.3 mRNA Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Therapeutic Vaccine
- 2.3.3 Therapeutic Drugs
- 2.3.4 Preventive Vaccines
- 2.4 mRNA Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital
- 2.4.3 Clinic
3 Market Competitive Landscape by Manufacturers
- 3.1 Global mRNA Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global mRNA Drug Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global mRNA Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global mRNA Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global mRNA Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of mRNA Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of mRNA Drug, Product Type & Application
- 3.8 Global Manufacturers of mRNA Drug, Established Date
- 3.9 Global mRNA Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Janssen
- 4.1.1 Janssen Company Information
- 4.1.2 Janssen Business Overview
- 4.1.3 Janssen mRNA Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Janssen mRNA Drug Product Portfolio
- 4.1.5 Janssen Recent Developments
- 4.2 Sri Lankan Microorganisms
- 4.2.1 Sri Lankan Microorganisms Company Information
- 4.2.2 Sri Lankan Microorganisms Business Overview
- 4.2.3 Sri Lankan Microorganisms mRNA Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Sri Lankan Microorganisms mRNA Drug Product Portfolio
- 4.2.5 Sri Lankan Microorganisms Recent Developments
- 4.3 Pfizer
- 4.3.1 Pfizer Company Information
- 4.3.2 Pfizer Business Overview
- 4.3.3 Pfizer mRNA Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Pfizer mRNA Drug Product Portfolio
- 4.3.5 Pfizer Recent Developments
- 4.4 Fosun Pharma
- 4.4.1 Fosun Pharma Company Information
- 4.4.2 Fosun Pharma Business Overview
- 4.4.3 Fosun Pharma mRNA Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Fosun Pharma mRNA Drug Product Portfolio
- 4.4.5 Fosun Pharma Recent Developments
- 4.5 AstraZeneca
- 4.5.1 AstraZeneca Company Information
- 4.5.2 AstraZeneca Business Overview
- 4.5.3 AstraZeneca mRNA Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 AstraZeneca mRNA Drug Product Portfolio
- 4.5.5 AstraZeneca Recent Developments
- 4.6 Zydus Cadila
- 4.6.1 Zydus Cadila Company Information
- 4.6.2 Zydus Cadila Business Overview
- 4.6.3 Zydus Cadila mRNA Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Zydus Cadila mRNA Drug Product Portfolio
- 4.6.5 Zydus Cadila Recent Developments
- 4.7 Moderna
- 4.7.1 Moderna Company Information
- 4.7.2 Moderna Business Overview
- 4.7.3 Moderna mRNA Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Moderna mRNA Drug Product Portfolio
- 4.7.5 Moderna Recent Developments
- 4.8 CureVAC
- 4.8.1 CureVAC Company Information
- 4.8.2 CureVAC Business Overview
- 4.8.3 CureVAC mRNA Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 CureVAC mRNA Drug Product Portfolio
- 4.8.5 CureVAC Recent Developments
- 4.9 BioNtech
- 4.9.1 BioNtech Company Information
- 4.9.2 BioNtech Business Overview
- 4.9.3 BioNtech mRNA Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 BioNtech mRNA Drug Product Portfolio
- 4.9.5 BioNtech Recent Developments
5 Global mRNA Drug Market Scenario by Region
- 5.1 Global mRNA Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global mRNA Drug Sales by Region: 2021-2032
- 5.2.1 Global mRNA Drug Sales by Region: 2021-2026
- 5.2.2 Global mRNA Drug Sales by Region: 2027-2032
- 5.3 Global mRNA Drug Revenue by Region: 2021-2032
- 5.3.1 Global mRNA Drug Revenue by Region: 2021-2026
- 5.3.2 Global mRNA Drug Revenue by Region: 2027-2032
- 5.4 North America mRNA Drug Market Facts & Figures by Country
- 5.4.1 North America mRNA Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America mRNA Drug Sales by Country (2021-2032)
- 5.4.3 North America mRNA Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe mRNA Drug Market Facts & Figures by Country
- 5.5.1 Europe mRNA Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe mRNA Drug Sales by Country (2021-2032)
- 5.5.3 Europe mRNA Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific mRNA Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific mRNA Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific mRNA Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific mRNA Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America mRNA Drug Market Facts & Figures by Country
- 5.7.1 South America mRNA Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America mRNA Drug Sales by Country (2021-2032)
- 5.7.3 South America mRNA Drug Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa mRNA Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa mRNA Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa mRNA Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa mRNA Drug Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global mRNA Drug Sales by Type (2021-2032)
- 6.1.1 Global mRNA Drug Sales by Type (2021-2032) & (k units)
- 6.1.2 Global mRNA Drug Sales Market Share by Type (2021-2032)
- 6.2 Global mRNA Drug Revenue by Type (2021-2032)
- 6.2.1 Global mRNA Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global mRNA Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global mRNA Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global mRNA Drug Sales by Application (2021-2032)
- 7.1.1 Global mRNA Drug Sales by Application (2021-2032) & (k units)
- 7.1.2 Global mRNA Drug Sales Market Share by Application (2021-2032)
- 7.2 Global mRNA Drug Revenue by Application (2021-2032)
- 7.2.1 Global mRNA Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global mRNA Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global mRNA Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 mRNA Drug Value Chain Analysis
- 8.1.1 mRNA Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 mRNA Drug Production Mode & Process
- 8.2 mRNA Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 mRNA Drug Distributors
- 8.2.3 mRNA Drug Customers
9 Global mRNA Drug Analyzing Market Dynamics
- 9.1 mRNA Drug Industry Trends
- 9.2 mRNA Drug Industry Drivers
- 9.3 mRNA Drug Industry Opportunities and Challenges
- 9.4 mRNA Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst